FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to pharmaceutical industry, and describes a combined pharmaceutical composition for treating chronic venous insufficiency, presented in a gel dosage form for external use, containing a combination of active substances in form of diosmin and troxerutin, as well as auxiliary substances from among gelling agents, antimicrobial preserving agents, penetrators, solvents, neutralizers of gelling agent and pH regulators, components of oil phase, emulsifiers and flavouring agents, easy to use and stable during long-term storage.
EFFECT: treatment of chronic venous insufficiency.
1 cl, 2 tbl, 18 dwg
Title | Year | Author | Number |
---|---|---|---|
COMBINED SOFT DOSAGE FORM OF DIOSMIN AND TROXERUTIN | 2018 |
|
RU2689409C1 |
COMBINED SOFT DOSAGE FORM FOR TREATING HAEMORRHOID DISEASES | 2018 |
|
RU2705794C1 |
PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE CONTAINING A SALT OF DEXKETOPROFEN, AND A PROCESS FOR ITS PREPARATION | 2015 |
|
RU2667465C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VEIN DISEASES AND METHOD FOR ITS PREPARING | 2005 |
|
RU2299070C2 |
TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
STABLE GEL FORM OF AZELAIC ACID | 2013 |
|
RU2557932C2 |
MEANS OF CHRONIC VENOUS INSUFFICIENCY TREATMENT | 2022 |
|
RU2797950C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING LOCOMOTOR DISORDERS | 2013 |
|
RU2550916C1 |
TRANSDERMAL AGENT FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES, METHOD FOR PRODUCTION THEREOF AND COMBINED TRANSDERMAL PREPARATION FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES | 2013 |
|
RU2582278C2 |
STABILISED PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES CAUSED BY VENOUS INSUFFICIENCY | 2011 |
|
RU2458694C1 |
Authors
Dates
2019-11-01—Published
2017-05-10—Filed